Angio-Seal Used as a Bailout for Incomplete Hemostasis After Dual Perclose ProGlide Deployment in Transcatheter Aortic Valve Implantation

Autor:	Çakal, Beytullah, Çakal, Sinem, Karaca, Oğuz, Kızılırmak Yılmaz, Filiz, Güneş, Hacı Murat, Yıldırım, Arzu, Özcan, Özgür Ulaş, Güler, Yeliz, Boztosun, Bilal
Rok vydání:	2022
Předmět:	Peripheral Artery Diseases Femoral Artery Transcatheter Aortic Valve Replacement Hemostasis Treatment Outcome Hemostatic Techniques Humans Vascular Access Device Hemorrhage Clinical Investigation Cardiology and Cardiovascular Medicine Vascular Closure Devices Retrospective Studies
Zdroj:	Tex Heart Inst J
ISSN:	1526-6702 0730-2347
Popis:	Background The failure rate of vascular closure devices remains a significant cause of major vascular complications in contemporary transcatheter aortic valve implantation practice. Methods This research aimed to evaluate use of the Angio-Seal device in a bailout context in the setting of incomplete hemostasis following use of dual Perclose ProGlide devices in patients undergoing transfemoral transcatheter aortic valve implantation. A total of 185 patients undergoing transfemoral transcatheter aortic valve implantation with either dual Per-close ProGlide (n = 139) or a combination of dual Perclose ProGlide and Angio-Seal (n = 46) were retrospectively analyzed. The baseline, procedural characteristics, and all outcomes (defined according to Valve Academic Research Consortium-2 criteria) were compared. Results No significant differences were seen between the dual Perclose ProGlide vs dual Perclose ProGlide+Angio-Seal groups with regard to the in-hospital Valve Academic Research Consortium-2 primary end points of major vascular complications (n = 13 [9.4%] vs n = 2 [4.3%]; P = .36), minor vascular complications (n = 13 [9.4%] vs n = 8 [14.7%]; P = .14), major bleeding (n = 16 [11.5%] vs n = 2 [4.3%]; P = .25), and minor bleeding (n = 9 [6.5%] vs n = 5 [10.9%]; P = .34), with higher rates of hematoma in the dual Perclose ProGlide+Angio-Seal group (n = 4 [2.9%] vs n = 5 [10.9%]; P = .044). Conclusion Finding from the current study suggest that adjunctive Angio-Seal deployment may be feasible and safe, especially in patients with incomplete hemostasis following dual Perclose ProGlide use, and can be an optimal “bailout” procedure.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b30e7892bbc1de95ab5326a99535a1 https://doi.org/10.14503/thij-21-7684 Zobrazit plný text záznamu